A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04738123 |
|
Recruitment Status :
Completed
First Posted : February 4, 2021
Last Update Posted : October 31, 2023
|
Sponsor:
Karuna Therapeutics
Information provided by (Responsible Party):
Karuna Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | November 29, 2022 |
| Actual Study Completion Date : | December 7, 2022 |
| Certification/Extension First Submitted : | October 27, 2023 |